Edge Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-1,276
| Closed | -$93K | – | 238 |
|
|
2021
Q4 | $93K | Buy |
1,276
+5
| +0.4% | +$344 | 0.02% | 139 |
|
|
2021
Q3 | $89K | Buy |
1,271
+60
| +5% | +$4.21K | 0.02% | 142 |
|
|
2021
Q2 | $83K | Buy |
1,211
+1
| +0.1% | +$67 | 0.02% | 151 |
|
|
2021
Q1 | $78K | Buy |
1,210
+3
| +0.2% | +$193 | 0.02% | 156 |
|
|
2020
Q4 | $70K | Sell |
1,207
-3,003
| -71% | -$181K | 0.02% | 160 |
|
|
2020
Q3 | $266K | Sell |
4,210
-8,810
| -68% | -$611K | 0.06% | 93 |
|
|
2020
Q2 | $1M | Sell |
13,020
-98,072
| -88% | -$7.52M | 0.19% | 67 |
|
|
2020
Q1 | $8.26M | Sell |
111,092
-15,871
| -13% | -$1.1M | 1.79% | 18 |
|
|
2019
Q4 | $8.21M | Buy |
126,963
+9,692
| +8% | +$631K | 1.64% | 20 |
|
|
2019
Q3 | $7.43M | Buy |
117,271
+60,575
| +107% | +$3.96M | 1.71% | 19 |
|
|
2019
Q2 | $3.83M | Buy |
56,696
+6,988
| +14% | +$460K | 0.85% | 33 |
|
|
2019
Q1 | $3.24M | Buy |
49,708
+18,399
| +59% | +$1.22M | 0.8% | 36 |
|
|
2018
Q4 | $1.96M | Sell |
31,309
-70,453
| -69% | -$4.92M | 0.55% | 36 |
|
|
2018
Q3 | $7.86M | Buy |
101,762
+4,552
| +5% | +$344K | 1.89% | 21 |
|
|
2018
Q2 | $6.89M | Buy |
97,210
+1,251
| +1% | +$88.3K | 1.75% | 20 |
|
|
2018
Q1 | $7.23M | Sell |
95,959
-15,599
| -14% | -$1.24M | 1.92% | 20 |
|
|
2017
Q4 | $8.02M | Sell |
111,558
-25,041
| -18% | -$1.9M | 2.27% | 15 |
|
|
2017
Q3 | $11M | Sell |
136,599
-3,637
| -3% | -$278K | 3.34% | 10 |
|
|
2017
Q2 | $9.92M | Sell |
140,236
-3,158
| -2% | -$210K | 3.12% | 9 |
|
|
2017
Q1 | $9.75M | Buy |
143,394
+88,899
| +163% | +$6.25M | 3.38% | 8 |
|
|
2016
Q4 | $3.9M | Buy |
54,495
+4,733
| +10% | +$352K | 1.48% | 23 |
|
|
2016
Q3 | $3.72M | Buy |
49,762
+6,261
| +14% | +$509K | 1.58% | 23 |
|
|
2016
Q2 | $3.62M | Buy |
43,501
+30,129
| +225% | +$2.67M | 1.51% | 24 |
|
|
2016
Q1 | $1.23M | Sell |
13,372
-1,147
| -8% | -$103K | 0.56% | 38 |
|
|
2015
Q4 | $1.48M | Buy |
14,519
+3,560
| +32% | +$370K | 0.56% | 39 |
|
|
2015
Q3 | $1.07M | Buy |
10,959
+310
| +3% | +$34.4K | 0.4% | 46 |
|
|
2015
Q2 | $1.25M | Sell |
10,649
-130
| -1% | -$14.2K | 0.43% | 41 |
|
|
2015
Q1 | $1.07M | Buy |
10,779
+35
| +0.3% | +$3.55K | 0.36% | 49 |
|
|
2014
Q4 | $1.02M | Buy |
10,744
+1,725
| +19% | +$178K | 0.37% | 44 |
|
|
2014
Q3 | $957K | Buy |
9,019
+416
| +5% | +$40.7K | 0.37% | 41 |
|
|
2014
Q2 | $715K | Buy |
8,603
+1,062
| +14% | +$82.7K | 0.3% | 48 |
|
|
2014
Q1 | $534K | Buy |
7,541
+371
| +5% | +$29.1K | 0.22% | 59 |
|
|
2013
Q4 | $538K | Hold |
7,170
| – | – | 0.25% | 49 |
|
|
2013
Q3 | $451K | Hold |
7,170
| – | – | 0.28% | 51 |
|
|
2013
Q2 | $368K | Buy |
+7,170
| New | +$374K | 0.25% | 43 |
|
Other funds holding GILD
Edge Wealth Management's GILD Position: Q1 2022 in Review
Edge Wealth Management sold out of Gilead Sciences (GILD) in Q1 2022, closing a stake of 1,276 shares — an estimated $93K sold.
Edge Wealth Management first reported a position in GILD in Q2 2013 and held it in 35 quarters. The position peaked at $11M in Q3 2017. 1,600 funds tracked by Wall St. Rank hold GILD as of Q1 2022.
- Edge Wealth Management reported no remaining Gilead Sciences position as of Q1 2022 after selling out during the quarter.
- Edge Wealth Management sold 1,276 Gilead Sciences shares in Q1 2022, an estimated $93K.
- Edge Wealth Management first reported a position in Gilead Sciences in Q2 2013 and held it in 35 quarters.
- Edge Wealth Management's Gilead Sciences position peaked at $11M in Q3 2017.
- 1,600 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.
Based on Edge Wealth Management's 13F filing for Q1 2022, filed 14 Apr 2022.